Terms: = Germ cell tumor AND CDC73, HRPT2, 79577, ENSG00000134371, HPT-JT, Q6P1J9, FLJ23316, C1orf28
18 results:
1. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis.
Zhang M; Zhou Z; Liu Z; Liu F; Zhao C
PeerJ; 2022; 10():e12768. PubMed ID: 35111402
[TBL] [Abstract] [Full Text] [Related]
2. A case report of multiple endocrine neoplasia type 1 and autoimmune disease: Coincidence or correlation?
Chaves C; Nunes da Silva T; Dias Pereira B; Anselmo J; Claro I; Cavaco BM; Saramago A; Leite V
Medicine (Baltimore); 2021 Dec; 100(49):e28145. PubMed ID: 34889280
[TBL] [Abstract] [Full Text] [Related]
3. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract] [Full Text] [Related]
4. Molecular Characterization of Appendiceal Goblet cell Carcinoid.
Arai H; Baca Y; Battaglin F; Kawanishi N; Wang J; Soni S; Zhang W; Millstein J; Johnston C; Goldberg RM; Philip PA; Seeber A; Xiu J; Hwang JJ; Shields AF; Marshall JL; Korn WM; Lenz HJ
Mol Cancer Ther; 2020 Dec; 19(12):2634-2640. PubMed ID: 33037134
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of a novel cdc73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
[TBL] [Abstract] [Full Text] [Related]
6. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
Cardoso L; Stevenson M; Thakker RV
Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
[TBL] [Abstract] [Full Text] [Related]
7. Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms.
Guerin C; Romanet P; Taieb D; Brue T; Lacroix A; Sebag F; Barlier A; Castinetti F
Endocr Relat Cancer; 2018 Feb; 25(2):T15-T28. PubMed ID: 28874394
[TBL] [Abstract] [Full Text] [Related]
8. Hyperparathyroidism-jaw tumor syndrome: Results of operative management.
Mehta A; Patel D; Rosenberg A; Boufraqech M; Ellis RJ; Nilubol N; Quezado MM; Marx SJ; Simonds WF; Kebebew E
Surgery; 2014 Dec; 156(6):1315-24; discussion 1324-5. PubMed ID: 25444225
[TBL] [Abstract] [Full Text] [Related]
9. Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion.
Yu W; McPherson JR; Stevenson M; van Eijk R; Heng HL; Newey P; Gan A; Ruano D; Huang D; Poon SL; Ong CK; van Wezel T; Cavaco B; Rozen SG; Tan P; Teh BT; Thakker RV; Morreau H
J Clin Endocrinol Metab; 2015 Feb; 100(2):E360-4. PubMed ID: 25387265
[TBL] [Abstract] [Full Text] [Related]
10. A novel cdc73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (hpt-jt) syndrome.
Chiofalo MG; Sparaneo A; Chetta M; Franco R; Baorda F; Cinque L; Granatiero M; D'Agruma L; Pezzullo L; Scillitani A; Guarnieri V
Cell Oncol (Dordr); 2014 Aug; 37(4):281-8. PubMed ID: 25113791
[TBL] [Abstract] [Full Text] [Related]
11. Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the cdc73 gene.
Pazienza V; la Torre A; Baorda F; Alfarano M; Chetta M; Muscarella LA; Battista C; Copetti M; Kotzot D; Kapelari K; Al-Abdulrazzaq D; Perlman K; Sochett E; Cole DE; Pellegrini F; Canaff L; Hendy GN; D'Agruma L; Zelante L; Carella M; Scillitani A; Guarnieri V
PLoS One; 2013; 8(12):e82292. PubMed ID: 24340015
[TBL] [Abstract] [Full Text] [Related]
12. The EIF4EBP3 translational repressor is a marker of cdc73 tumor suppressor haploinsufficiency in a parathyroid cancer syndrome.
Zhang JH; Seigneur EM; Pandey M; Loshakov A; Dagur PK; Connelly PS; Koo L; Panicker LM; Simonds WF
Cell Death Dis; 2012 Feb; 3(2):266. PubMed ID: 22297294
[TBL] [Abstract] [Full Text] [Related]
13. [Multiple endocrine neoplasia: genetic aspects].
Calender A;
Bull Acad Natl Med; 2010 Jan; 194(1):81-95; discussion 95-6. PubMed ID: 20669561
[TBL] [Abstract] [Full Text] [Related]
14. Origin of renal cell carcinomas.
Valladares Ayerbes M; Aparicio Gallego G; Díaz Prado S; Jiménez Fonseca P; García Campelo R; Antón Aparicio LM
Clin Transl Oncol; 2008 Nov; 10(11):697-712. PubMed ID: 19015066
[TBL] [Abstract] [Full Text] [Related]
15. Human RNA polymerase II-associated factor complex: dysregulation in cancer.
Chaudhary K; Deb S; Moniaux N; Ponnusamy MP; Batra SK
Oncogene; 2007 Nov; 26(54):7499-507. PubMed ID: 17599057
[TBL] [Abstract] [Full Text] [Related]
16. [Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].
Raue F; Haag Ch; Frank-Raue K
Dtsch Med Wochenschr; 2007 Jul; 132(27):1459-62. PubMed ID: 17583828
[TBL] [Abstract] [Full Text] [Related]
17. [Genetics of endocrine tumours].
Calender A; Dupasquier S; Cordier M; Zhang CX;
Ann Pathol; 2005 Dec; 25(6):463-86. PubMed ID: 16735973
[TBL] [Abstract] [Full Text] [Related]
18. A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome.
Haven CJ; Wong FK; van Dam EW; van der Juijt R; van Asperen C; Jansen J; Rosenberg C; de Wit M; Roijers J; Hoppener J; Lips CJ; Larsson C; Teh BT; Morreau H
J Clin Endocrinol Metab; 2000 Apr; 85(4):1449-54. PubMed ID: 10770180
[TBL] [Abstract] [Full Text] [Related]
